6 Vote!

FDA panel backs previously rejected obesity pill

(AP) -- A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns....

read more...

Share |

Source: PhysOrg - Wednesday, 22 February


Related articles: